1294 related articles for article (PubMed ID: 26034365)
21. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
22. Prognostic evaluation of patients undergoing living-donor liver transplant by APACHE II and MELD scores.
Zhang ZY; Chen R; Zhou ZQ; Peng CH; Zhou GW
Exp Clin Transplant; 2015 Feb; 13(1):41-5. PubMed ID: 24779711
[TBL] [Abstract][Full Text] [Related]
23. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
[TBL] [Abstract][Full Text] [Related]
24. Serum sodium and survival benefit of liver transplantation.
Sharma P; Schaubel DE; Goodrich NP; Merion RM
Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
[TBL] [Abstract][Full Text] [Related]
25. Living donor liver transplantation for post-Kasai biliary atresia: Analysis of pretransplant predictors of outcomes in infants.
Kitajima T; Sakamoto S; Sasaki K; Uchida H; Narumoto S; Fukuda A; Teramukai S; Uemoto S; Kasahara M
Liver Transpl; 2017 Sep; 23(9):1199-1209. PubMed ID: 28590589
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for abdominal bleeding after living-donor liver transplant.
Li C; Wen TF; Yan LN; Li B
Exp Clin Transplant; 2014 Oct; 12(5):424-8. PubMed ID: 24568675
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.
Li C; Wen TF; Yan LN; Li B; Yang JY; Xu MQ; Wang WT; Wei YG
Ann Hepatol; 2012; 11(4):471-7. PubMed ID: 22700628
[TBL] [Abstract][Full Text] [Related]
29. No Child Left Behind: Liver Transplantation in Critically Ill Children.
Rana A; Kueht M; Desai M; Lam F; Miloh T; Moffett J; Galvan NT; Cotton R; O'Mahony C; Goss J
J Am Coll Surg; 2017 Apr; 224(4):671-677. PubMed ID: 28167225
[TBL] [Abstract][Full Text] [Related]
30. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
[TBL] [Abstract][Full Text] [Related]
31. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
[TBL] [Abstract][Full Text] [Related]
32. Predictors and impacts of hospital readmissions following liver transplantation.
Yataco M; Cowell A; David W; Keaveny AP; Taner CB; Patel T
Ann Hepatol; 2016; 15(3):356-62. PubMed ID: 27049489
[TBL] [Abstract][Full Text] [Related]
33. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
[TBL] [Abstract][Full Text] [Related]
34. Biliary complications adversely affect patient and graft survival after liver retransplantation.
Enestvedt CK; Malik S; Reese PP; Maskin A; Yoo PS; Fayek SA; Abt P; Olthoff KM; Shaked A
Liver Transpl; 2013 Sep; 19(9):965-72. PubMed ID: 23818332
[TBL] [Abstract][Full Text] [Related]
35. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
36. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
[TBL] [Abstract][Full Text] [Related]
37. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
[TBL] [Abstract][Full Text] [Related]
38. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
39. Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher.
Alexopoulos S; Matsuoka L; Cho Y; Thomas E; Sheikh M; Stapfer M; Dhanireddy K; Sher L; Selby R; Genyk Y
Transplantation; 2013 Feb; 95(3):507-12. PubMed ID: 23380865
[TBL] [Abstract][Full Text] [Related]
40. Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age.
Chapman WC; Vachharajani N; Collins KM; Garonzik-Wang J; Park Y; Wellen JR; Lin Y; Shenoy S; Lowell JA; Doyle MB
J Am Coll Surg; 2015 Jul; 221(1):59-69. PubMed ID: 25872684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
